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Abstract
Ethoxyquin (EQ; 6-Ethoxy-2,2,4-trimethyl-1,2-dihydroquinoline) has been used as an anti-
oxidant in feed components for pets, livestock and aquaculture. However, possible risks of
EQ used in aquafeed for fish health have not yet been characterized. The present study
investigated the toxicity and dose-response of subchronic dietary EQ exposure at doses
ranging from 41 to 9666 mg EQ/kg feed in Atlantic salmon (Salmo salar L.). Feed at concen-
trations higher than 1173 mg EQ/kg were rejected by the fish, resulting in reduced feed
intake and growth performance. No mortality was observed in fish exposed to any of the
doses. A multi-omic screening of metabolome and proteome in salmon liver indicated an
effect of dietary EQ on bioenergetics pathways and hepatic redox homeostasis in fish fed
concentrations above 119 mg EQ/kg feed. Increased energy expenditure associated with
an upregulation of hepatic fatty acid β-oxidation and induction and carbohydrate catabolic
pathways resulted in a dose-dependent depletion of intracytoplasmic lipid vacuoles in liver
histological sections, decreasing whole body lipid levels and altered purine/pyrimidine
metabolism. Increased GSH and TBARS in the liver indicated a state of oxidative stress,
which was associated with activation of the NRF2-mediated oxidative stress response and
glutathione-mediated detoxification processes. However, no oxidative DNA damage was
observed. As manifestation of altered energy metabolism, the depletion of liver intracyto-
plasmic lipid vacuoles was considered the critical endpoint for benchmark dose assess-
ment, and a BMDL10 of 243 mg EQ/kg feed was derived as a safe upper limit of EQ
exposure in Atlantic salmon.
Introduction
During storage, animal feed may be subject to auto-oxidation induced lipid peroxidation,
which can result in feed rancidity and reduced shelf life. Ethoxyquin (6-Ethoxy-2,2,4-tri-
methyl-1,2-dihydroquinoline; EQ) is one of a number of technological antioxidant feed
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additives added to animal feeds to prevent this process from happening. Because of its high
antioxidant capacity [1], EQ has commonly been used in fishmeal to prevent rancidity, but
also to prevent self-ignition under long-distance sea transport and storage. In addition, EQ has
routinely been added to fish silage as well as vitamin and pigment premixes in order to pre-
serve nutritive value, freshness, flavor and color of these products. In the European Union
(EU), the upper limit (UL) for use of EQ alone or in combination with two other authorized
synthetic antioxidants, namely butylated hydroxy toluene (BHT) and butylated hydroxyanisole
(BHA), in animal feed was previously established at 150 mg/kg (Council Directive 70/524/
EEC, replaced by Council Regulation (EC) No. 1831/2003 [2,3]). Results from an annual feed
monitoring program commissioned by the Norwegian Food Safety Authorities showed that
during the years 2003–2017 the average EQ concentration in Norwegian fish feeds was 20 ± 25
mg/kg (including both EQ and its main metabolite ethoxyquin dimer (EQDM); n = 607) [4].
Few non-compliant feeds exceeding authorized levels have been found during these years,
with a maximum deteced concentration of 180 mg EQ/kg (224 mg ∑EQ+EQDM/kg) [4].
However, the presence of EQ in feed may result in an accumulation of both EQ and its break-
down products in the edible parts of farmed animals [5,6]. In several farmed fish species
including, Atlantic cod (Gadus morhua), Atlantic salmon (Salmo salar), Atlantic halibut (Hip-
poglossus hippoglossus) and brown trout (Salmo trutta), the presence of EQ and its metabolites
was confirmed [7]. In the EU, the authorization of EQ as a feed additive in the food production
chain is currently under re-evaluation, and has meanwhile been formally suspended, because
of a substantial lack of relevant toxicological data required for a risk assessment [8,9].
Several studies have indicated undesirable health-effects in animals fed diets containing EQ
[10]. Yet, to date limited information is available on possible effects and effect levels of EQ
present in fish feed [8]. In the large yellow croaker (Pseudosciaena crocea), ten weeks dietary
exposure to 1350 mg EQ/kg feed decreased specific growth rate, condition factor and hepato-
somatic index [11]. Furthermore, indications of perturbation of the lipid metabolism were
seen at whole fish level with a curvilinear dose-response of crude lipid content to increasing
concentrations of EQ. In turbot (Scophthalmus maximus L.), disturbed iono-regulatory mech-
anisms were suggested in fish exposed for 16 days to 200 and 400 mg EQ/kg feed, affecting
plasma concentrations of sodium, chloride and calcium [12]. In tilapia (Oreochromis niloticus),
30 days of dietary exposure to 150 mg EQ/kg feed was found to have immunosuppressive
effects and cause histopathological changes in the liver [13]. In Atlantic salmon (Salmo salar
L.), EQ was shown to affect gene and protein expression patterns associated with the hepatic
biotransformation of EQ through Phase I and II catalytic enzymes such as CYP1A1, CYP3A,
GST and UDPGT after 90 days exposure to doses of up to 1800 mg/kg feed. However, no dif-
ferences were seen in growth rate, feed conversion rate, hepato-somatic index or mortality
[5,14].
In light of the scarce and conflicting data on EQ toxicity in farmed fish, the aim of the pres-
ent study was to comprehensively investigate the toxicity and mode of action of subchronic
dietary exposure to EQ in Atlantic salmon, using a systems biological approach. Five graded
doses of EQ were administered to salmon through the diet and effects on health status were
screened in liver, kidney, spleen and plasma. As a primary screening, metabolomic and proteo-
mic profiling were performed and integrated in order to explore possible treatment-related
changes and the interactions between different interconnected metabolic pathways. Identified
target pathways were subsequently investigated by more targeted analyses using traditional
physiological and biochemical measures to consolidate if these candidate pathways were of sig-
nificance for the development of adverse outcomes. In order to characterize the risk from the
dietary intake of EQ in Atlantic salmon, experimental data of toxicological responses were ana-
lyzed using benchmark dose models (BMD). The dose threshold for a toxic effect [15] was
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determined from the BMD of the critical endpoint of the study from which a safe upper level
of intake for EQ for Atlantic salmon was proposed.
Materials and methods
Ethical statement
The experiment was approved by the Norwegian National Animal Research Authority (Mattil-
synet; FOTS ID: 9004) and was performed in compliance with national and international ethi-
cal standards.
Diet preparation
The experiment was designed as a subchronic oral toxicity study according to [16], including
six dietary treatments. EQ-free diets were produced in one batch as 5 mm extruded pellets by
EWOS Innovation (Bergen, Norway), according to an established recipe (Harmony Debio,
organic fish feed; Table 1). The levels of EQ were adjusted by dissolving commercially available
EQ (Capsoquin batch no. S-5162, 99% purity; courtesy of Industrial Te´cnica Pecuaria, S.A.,
Spain) directly into oil with subsequent coating of the pellets, aiming to obtain nominal EQ
concentrations of 0, 50, 150, 1500, 5000 and 10 000 mg EQ/kg feed. Uncoated feed pellets with
a lipid content 20% below the target level were mixed with EQ-containing fish oil and exposed
to a reduced pressure of 0.1 bar for 10 min. The resulting oil-coated pellets were stored at
Table 1. Formulation and proximate composition of 5 mm fish feed pellets spiked with graded levels of ethoxy-
quin (EQ) and fed to Atlantic salmon (Salmo salar L.) for 90 days.






Fish protein concentratef 60.0
Microingredientsg 26.9
Total 1000.0
———Proximate analyses (% ww)1 ———
Crude protein (N�6.25) 48.3 ± 2.4
Lipid 25.3 ± 1.8
Ash 5.8 ± 0.1
Dry matter 93.7 ± 0.5
a Organic fish meal Norsildmel, Norway.
b Soy protein concentrate, pea protein concentrate, wheat gluten.
c Northern hemisphere fish oil.
d Commodity, European origin.
e Commodity, European origin.
f Aquarius AS, Norway.
g Vitamin E 50 (DL-alpha tocopherol), vitamin C 35% (mono-phosphate ascorbic acid). The vitamin and mineral
mixture was prepared in order to meet the nutritional requirements of salmon as established by the National
Research Council (2011).
1 Feed analyses were performed in technical duplicates. Given values represent the mean ± standard deviation of 6
parallel measurements.
https://doi.org/10.1371/journal.pone.0211128.t001
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-20˚C throughout the experimental period. Concentrations of EQ and its main metabolite
EQDM were measured in samples from each feed batch taken immediately after production
(Table 2) and again after the 90 days feeding experiment. Ethoxyquin concentrations in feed
were 0.47 mg (EQ 0), 41 ± 2 mg (EQ 1), 119 ± 7 mg (EQ 2), 1173 ± 113 mg (EQ 3), 3985 ± 228
mg (EQ 4) and 9666 ± 979 mg/kg feed at trial start, and did not show any degradation during
the experimental period. Concentrations of EQDM were below the limit of quantification
(LOQ <0.07 mg EQDM/kg feed) at both time points. To ensure nutritive stability of the con-
trol feed containing no added EQ, Vitamin E (500 mg/kg) and C (1 g/kg) were added as anti-
oxidants to all diets. Analyses of the experimental diets confirmed equality of the proximate
dietary composition between the different feeds. Measured levels of TBARS and vitamin E in
the experimental diets were comparable (Table 2), and indicated oxidative stability of the diets
throughout the experimental period.
Experimental conditions and sampling
The feeding trial was carried out at NOFIMA (Sunndalsøra, Norway) between July and Octo-
ber 2016. A total of 1260 individuals of 6 months old Atlantic salmon smolt (Salmo salar, L.)
with an average initial weight of 150–200 g were randomly distributed into 18 tanks with 70
fish in each tank. All fish were sorted from the same group and shared the same genetic and
environmental background. In order to maintain group homogeneity, fish deviating from the
target size (± 15%) were discarded.
Fish were kept in indoor flow-through tanks with a surface area of 1.4 m2 and approxi-
mately 840 l water volume, under a photoperiod regime with 24h light. Water temperature,
pH, oxygen availability and salinity were monitored daily during the experiment. Prior to trial
start, the fish were acclimatized in their tanks on control feed containing no added EQ for a
period of 14 days. Subsequently, three tanks were randomly assigned to each of the six experi-
mental groups, and the fish were fed the experimental feeds for 90 days. The feeding regime
was based on automatic feeders. Six daily meals were provided with four hours between the
meals. Unconsumed feed pellets were collected and weighed once per day, and feed intake,
feed conversion and EQ exposure were calculated.
Ten fish per tank (n = 30 per treatment group) were collected after both 45 and 90 days of
exposure for tissue sampling. In addition, five fish per tank from the dietary group receiving
an EQ concentration of ~150 mg/kg feed (EQ 2) were sampled at T = 0, and after 2, 4, 10, 20,
45 and 90 days of exposure, in order to monitor accumulation kinetics in fish fillet (results not
reported here). In order to ensure equal treatment of all tanks, the number of fish in the other
treatment groups was adjusted accordingly.
Table 2. Concentrations of ethoxyquin (EQ), vitamin E and TBARS in the experimental diets fed to Atlantic salmon (Salmo salar L.) for 90 days.
EQ (mg/kg ww) Vitamin E (mg/kg ww) TBARS
(nmol/g ww)Experimental diet Intended Analyzed α-tocopherol γ-tocopherol
EQ 0 0 0.47 560 45 11.0
EQ 1 50 41 ± 2 670 47 12.0
EQ 2 150 119 ± 7 540 43 10.0
EQ 3 1500 1173 ± 113 650 44 9.8
EQ 4 5000 3985 ± 228 550 42 8.8
EQ 5 10000 9666 ± 979 570 40 9.2
EQ measurements were performed in technical duplicate. Given analyzed values represent the mean of one measurement in technical duplicate (EQ 0) or the
means ± standard deviation of 4 parallel measurements performed in technical duplicates (EQ 1–EQ 5).
https://doi.org/10.1371/journal.pone.0211128.t002
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During sampling, fish were randomly collected from the tanks, anesthetized in a bath of tri-
caine methanesulfonate (FINQUEL MS-222; ~ 60mg L-1). Fish were sacrificed by a blow on
the head and body weight and length of each fish were recorded. Five fish of each tank were
homogenized to one pooled sample per tank for analysis of proximate composition. Of the five
remaining fish, blood samples were taken from the caudal vein quickly following the initial
anesthetization, using a heparinized VACUETTE blood collection tube with 21G x 1’ needle
and kept on ice until further analyses and plasma separation. Liver, kidney, heart and spleen
were collected and organ weights were recorded. Defined pieces of liver, kidney and spleen
were fixed in 4% (v/v) formaldehyde (in PBS) for histopathological evaluation, while the rest
of the tissue was immediately frozen in liquid nitrogen and kept at -80˚C until further analysis.
Individual muscle samples (Norwegian quality cut; NQC) were taken, homogenized, frozen
and stored at -80˚C.
Calculations
In order to assess growth performance and EQ exposure of Atlantic salmon during the 90 days
feeding trial, body weight gain, condition factor, specific growth rate, feed intake and feed con-
version rate were calculated with the following equations:
Body weight gain ¼ Final body weight ðgÞ   Mean initial body weight ðgÞ ð1Þ
Condition factor kð Þ ¼
Final body weight ðgÞ
Final body length ðcmÞ3
 !
� 100 ð2Þ
Specific growth rate ¼
lnðFinal body weight ðgÞÞ   lnðMean initial body weightðgÞÞ
90 days of feeding experiment
� �
� 100 ð3Þ
Daily feed intake � fish  1 ¼
Recorded feed intake � tank  1 � day  1ðgÞ
Number of fish � tank  1
ð4Þ
Total feed intake � fish  1 ¼
P
Daily feed intake � fish  1ðgÞ ð5Þ
Feed conversion rate ¼
Total feed intake � fish  1ðgÞ
Body weight gain ðgÞ
� �
ð6Þ
Estimated daily EQ exposure ¼
ðDaily feed intake � fish  1ðgÞÞ � Concentration of EQ in feed ðmg=kgÞ
Interpolated body weight ðkgÞ
� �
ð7Þ
Organ somatic indices were calculated as the ratio of organ- to body weight.
Quantification of ethoxyquin (EQ) and ethoxyquin dimer (EQDM)
The concentrations of EQ and EQDM in salmon muscle, whole body homogenates of five fish
per tank (n = 3 tanks/group) and in salmon feed were performed as previously described by
Bohne et al. [14], with modifications described by Ørnsrud et al. [17]. Briefly, EQ and EQDM
were extracted with hexane from five individual muscle and five whole body homogenate sam-
ples per tank after saponification in ethanol-NaOH, or directly with 0.1% (w/v) solid acetic
acid in acetonitrile from feed samples. Subsequently, the contents of EQ and EQDM were
quantified by reversed-phase high-performance liquid chromatography (HPLC) with fluores-
cence detection, using an external standard curve.
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Proximate composition of diets and whole fish homogenates
Nitrogen content in feed samples and whole fish homogenates of five fish per tank (n = 3
tanks/group) was determined using a Vario Macro Cube (VMC) nitrogen analyzer according
to AOAC [18], and crude protein was calculated as N�6.25. Total lipid content in feed samples
was measured gravimetrically after acid hydrolysis or extraction with ethyl acetate from fish
samples. Ash and dry matter were measured gravimetrically after ashing at 550 ± 5˚C over-
night or freeze drying for 48h, respectively.
Vitamin E measurement
Vitamin E was extracted with hexane from feed and liver samples of five fish per tank (n = 3
tanks/group), after saponification with ethanol/ KOH. Tocopherol and tocotrienol isomers
were quantified by HPLC with fluorescence detection, using an external standard curve as
described by Lie et al. [19].
Thiobarbituric acid reactive substances (TBARS)
Lipid peroxidation in feed and liver samples of five fish per tank (n = 3 tanks/group) was
assessed through measurement of TBARS. The concentrations of TBARS were determined
spectrophotometrically as described by Hamre et al. [20].
Liver metabolomic profiling
In order to identify possible effects of dietary EQ exposure on liver metabolism, global metabo-
lite profiles were determined in livers of Atlantic salmon from all dietary treatments (three ran-
domly chosen fish per tank, 45 fish total) after 90 days of feeding. Metabolite profiling was
performed by Metabolon Inc., USA, according to Metabolon’s standard methods. Briefly, sam-
ples were extracted and prepared for analysis, using the automated MicroLab STAR system
(Hamilton Company, NV, USA). To remove protein, dissociate small molecules bound to pro-
tein or trapped in the precipitated protein matrix, and to recover chemically diverse metabo-
lites, proteins were precipitated with methanol under vigorous shaking for 2 min (Glen Mills
GenoGrinder 2000) followed by centrifugation. The sample extracts were then divided into
four fractions. The organic solvent was removed, briefly placing the samples on a TurboVap
(Zymark), the sample extracts were stored over night under nitrogen. All samples were ana-
lyzed using a combination of reverse phase (RP) ultra performance liquid chromatography
mass spectrometry (UPLC-MS/MS) with positive and negative ion mode electrospray ioniza-
tion (ESI), and hydrophilic interaction (HILIC) UPLC-MS/MS with negative ion mode ESI
along with several internal standards. In preparation for the analyses, the sample extracts were
dried and then reconstituted in solvents compatible to each of four methods. To quantify
more hydrophilic compounds, one aliquot was analyzed using acidic positive ion conditions,
gradient eluting the extract from a C18 column (Waters UPLC BEH C18-2.1x100 mm,
1.7 μm) using water and methanol, containing 0.05% perfluoropentanoic acid (PFPA) and
0.1% formic acid (FA). Another aliquot was also analyzed using acidic positive ion conditions,
but chromatographically optimized for more hydrophobic compounds. For this method, the
extract was gradient eluted from the same C18 column using methanol, acetonitrile, water,
0.05% PFPA and 0.01% FA and was operated at an overall higher organic content. The third
aliquot was analyzed using basic negative ion optimized conditions, gradient eluting the basic
extracts using a separate dedicated C18 column using methanol and water, however with
6.5mM Ammonium Bicarbonate at pH 8. The fourth aliquot was analyzed via negative ioniza-
tion following elution from a HILIC column (Waters UPLC BEH Amide 2.1x150 mm, 1.7 μm)
Toxicity of dietary ethoxyquin in Atlantic salmon
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using a gradient consisting of water and acetonitrile with 10mM Ammonium Formate at a pH
of 10.8. The MS analysis alternated between MS and data-dependent MSn scans using
dynamic exclusion. All methods utilized a Waters ACQUITY UPLC and a Thermo Scientific
Q-Exactive high resolution/accurate mass spectrometer coupled to a heated electrospray ioni-
zation source and an Orbitrap mass analyzer operated at 35 000 mass resolution.
Instrument variability was 5% for internal standards and total process variability for endog-
enous metabolites was 10%. Known compounds were identified by comparison to metabolo-
mics library entries of purified standards.
Liver proteomic profiling
Protein extraction from livers and tryptic protein digestions were performed on one randomly
chosen fish per tank (n = 3/group) from the EQ 0, EQ 1, EQ 2 and EQ 3 groups at the Proteo-
mics Unit at the University of Bergen, Norway (PROBE), according to in-house standardized
protocols. In short, liver tissue samples were lyzed by sonication in 10μl lysis buffer/mg tissue
(4% SDS, 0.1M Tris-HCl pH 7.6), using an ultrasonication rod (Q55 Sonicator, Qsonica, CT,
USA) at 30% amplitude for 30 sec, or until tissue was dissolved. The lysed tissue was then incu-
bated at 95˚C for 7 min, and centrifuged for 10 min at 13000 rpm. The supernatant was col-
lected and protein concentration determined Pierce BCA Protein assay kit (Thermo Scientific).
1M DiThiotreitol was added to the lysates, to obtain a final concentration of 0.1M, and the mix
was incubated at 95˚C for 5 min. The samples were further processed using a Filter Aided Sam-
ple Preparation (FASP) protocol with trypsin digestion as described by Wiśniewski et al. [21].
For Orbitrap Elite data-dependent-acquisition (DDA) analysis, between 0.5 and 1 ug pro-
tein, dissolved as tryptic peptides in 2% acetonitrile (ACN), 0.1% formic acid (FA), were
injected into an Ultimate 3000 RSLC system (Thermo Scientific, Sunnyvale, California, USA)
connected online to a linear quadrupole ion trap-orbitrap (LTQ-Orbitrap Elite) mass spec-
trometer (Thermo Scientific, Bremen, Germany), which in turn was equipped with a nanos-
pray Flex ion source (Thermo Scientific). The sample was loaded and desalted on a pre-
column (Acclaim PepMap 100, 2cm x 75μm ID nanoViper column, packed with 3μm C18
beads) at a flow rate of 5μl/min for 5 minutes (min) with 0.1% trifluoroacetic acid (TFA). Pep-
tides were separated during a biphasic ACN gradient from two nanoflow UPLC pumps (flow
rate of 270 nl /min) on a 50 cm analytical column (Acclaim PepMap 100, 50 cm x 75μm ID
nanoViper column, packed with 3 μm C18 beads). Solvent A and B was 0.1% TFA (vol/vol) in
water and 100% ACN, respectively. The gradient composition was 5% B during trapping
(5min) followed by 5–7% B (over 1min), 7–21% B (134min), 21–34% B (45min), and 34–80%
B (10min). Elution of very hydrophobic peptides and conditioning of the column were per-
formed during 20 minutes isocratic elution with 80% B and 20 minutes isocratic elution with
5% B, respectively.
The eluting peptides from the LC-column were ionized in the electrospray and analyzed by
the LTQ-Orbitrap Elite. The mass spectrometer was operated in DDA-mode to automatically
switch between full scan MS and MS/MS acquisition. Instrument control was through Tune
2.7.0, and Xcalibur 2.2. Survey full scan MS spectra (from m/z 300 to 2,000) were acquired in
the Orbitrap with a resolution of R = 240,000 at m/z 400 (after accumulation to a target value
of 1e6 in the linear ion trap with maximum allowed ion accumulation time of 300ms). The 12
most intense eluting peptides above an ion threshold value of 3000 counts, and charge states of
two or higher, were sequentially isolated to a target value of 1e4 and fragmented in the high-
pressure linear ion trap by low-energy CID (collision-induced-dissociation) with normalized
collision energy of 35% and wideband-activation enabled. The maximum allowed accumula-
tion time for CID was 150 ms, the isolation with maintained at 2 Da, activation q = 0.25, and
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activation time of 10 ms. The resulting fragment ions were scanned out in the low-pressure
ion trap at normal scan rate, and recorded with the secondary electron multipliers. One MS/
MS spectrum of a precursor mass was allowed before dynamic exclusion for 40s. Lock-mass
internal calibration was not enabled.
Prior to statistical analysis, the proteomics data were further processed using MaxQuant
(version 1.6.0.1) and Perseus (version 1.6.0.2) as described in Tyanova et al. [22,23]. In short,
MaxQuant running the built-in search engine Andromeda and protein sequences of the com-
plete Salmo salar (Atlantic salmon) reference proteome downloaded from Uniprot (http://www.
uniprot.org/proteomes/UP000087266) were used for protein identification and quantification
[24]. For protein identification, carbamidomethylation of cysteines and protein N-terminal
acetylation as well as oxidation of methionines were set as fixed modification and variable modi-
fication, respectively. Precursor mass tolerance was set to 4.5 ppm and 20 ppm were used for
fragment ion identification. Up to two missed cleavages were allowed for trypsin digestion.
Within MaxQuant, the software option “Match between runs” was enabled. The false discovery
rates (FDR) for peptide and protein identifications were set to 1%. Only unique peptides were
used for label-free quantification (LFQ). The MaxQuant output file was loaded into Perseus. Pro-
teins identified only by site and reverse hits were removed from the dataset. Subsequently, the
data was log2 transformed and the samples were grouped in to their respective categories. Rele-
vant protein expression data including LFQ intensities, molecular weight, fold changes, statistical
significance and protein accession numbers for protein identification are provided in S6 Table.
Hematology
Hematocrit (Hct) was determined immediately from sampled blood of five fish per tank (n = 3
tanks/group) using Vitex Pari microhematocrit capillary tubes (Vitrex Medical A/S, Denmark)
and a microhematocrit centrifuge (Haematofuge, Heraeus-Christ GmbH, Germany). The
number of red blood cells (RBC) and amount of hemoglobin (Hb) in full blood were measured
in a Cell Dyn 400 Hematological Analyzer (Sequoia- Turner) according to the manufacturer’s
instructions, using Para 12 Extend control blood (Streck, MedMark Ref:218777) for calibra-
tion. Mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH) and mean cor-
puscular hemoglobin concentration (MCHC) were calculated from Hct, RBC and Hb as
described in Sandnes et al. [25]. For a differential white blood cell count, blood smears were
prepared on glass slides from a drop of heparinized blood. The smears were air dried, fixed in
methanol for 5 min at room temperature, and stained with 50% May-Gru¨nwald (Merck, Ger-
many) and 10% Giemsa (Merck, Germany). The slides were examined in a light microscope
using 60x and 100x magnifications, and a total of 100 leucocytes were counted and classified as
neutrophils, lymphocytes or monocytes.
Plasma biochemistry
Blood samples of five fish per tank (n = 3 tanks/group) were centrifuged at 3500g for 10 min to
obtain the plasma fraction. The plasma was separated into aliquots, snap-frozen in liquid
nitrogen and stored at -80˚C until further analysis. Plasma concentrations of albumin and
total protein, alanine aminotransferase (ALT), aspartate aminotransferase (AST), bile acids,
bilirubin, creatinine and lysozyme were measured on a PL multipurpose diagnostic analyzer
(Maxmat S.A., Montpellier, France) using DIALAB diagnostic kits (Vienna, Austria).
Osmolality was assessed by freezing point determination, using a Fiske One-Ten osmome-
ter (Fiske, VT, USA). Sodium, potassium, chloride and free calcium in plasma were deter-
mined using the Radiometer ABL-77 Blood gas and electrolyte analyzer (Radiometer,
Copenhagen, Denmark).
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Liver redox-homeostasis
In order to assess oxidative stress, the concentrations of reduced and oxidized glutathione (GSH
and GSSG, respectively) in the liver were measured. Frozen liver tissue samples of five fish per
tank (n = 3 tanks/group) were weighed and homogenized in either four times the volume of
ice-cold 0.9% (w/v) saline buffer (9 g/L NaCl in ddH2O) for GSH analyses, or two times the
volume of ice-cold thiol scavenger (N-ethylmaleimide pyridine derivative solution, Cat. No.
GT35c; Oxford Biomedical Research, MI, USA) diluted 3:7 in 0.9% (w/v) saline buffer for GSSG
analyses, using a ball mill (25 rpm for 1–2 min; Retsch MM301 ball mill, Haan, Germany). The
homogenates were then centrifuged (5 min, 1500g, 4˚C), and the supernatant was transferred to
new tubes. The samples were further prepared using the Cuvette Assay kit for GSH/GSSG (Cat.
No. GT35; Oxford Biomedical Research, MI, USA) following the manufacturer’s instructions,
and GSH and GSSG were analyzed spectrophotometrically for absorbance at 405 nm in a Wal-
lac VICTOR X5 2030 Multilabel Reader (PerkinElmer Life Sciences, MA, USA).
Oxidative DNA damage
For assessment of oxidative DNA damage, genomic DNA was extracted from liver tissue using the
AllPrep DNA/RNA Mini Kit (Qiagen, Germany). The formation of 8-hydroxy-2’-deoxyguanosine
(8-oxo-dG) and apurinic/apyrimidinic (AP) sites was quantified in pooled DNA samples of five
fish per tank (n = 3 tanks/group) using the commercial kits HT 8-oxo-dG ELISA kit II (Trevigen
Inc., MD, USA) and OxiSelect Oxidative DNA Damage Quantitation Kit (AP sites) (both Cell Bio-
labs INC., CA, USA), following the manufacturer’s instructions. Results are expressed as nM
8-oxo-dG per unit DNA (ug/ul) and AP sites per 105 base pairs (bp), respectively.
Histology
Tissue samples of liver, spleen and kidney of five fish per tank were fixed in 4% (v/v) formalde-
hyde overnight, washed in PBS and then stored in 70% (v/v) ethanol until further processing.
The fixed tissues were further dehydrated through graded alcohols and xylene, and finally
embedded in paraffin. Tissue sections of 5 μm were then stained with hematoxylin and eosin
(H&E) and periodic acid-Schiff stain (PAS) for histopathological evaluation. In addition, the
special staining Pearl’s Prussian blue was employed to evaluate the presence of iron-derived
pigments. Sections were scanned with a ZEISS Axio Scan.Z1 (Carl Zeiss A/S, Birkeroed, Den-
mark). The histopathological changes were evaluated in each tissue based on the spectrum of
lesions, and presence was graded giving scores from 0–2 or 0–3. All analyses were performed
in a double-blinded format.
Statistical and bioinformatic analyses
Statistical data analysis was performed in R, version 3.4.0 [26]. Measurements performed on
tank pooled samples or tank means (n = 3/group) were analyzed with one-way ANOVA and
Tukey’s test for multiple comparison of group means. Normal distribution of the model resid-
uals and homogeneity of variance amongst treatment groups were tested using the Shapiro-
Wilk test and Levene’s F-test, respectively. Data not complying with the criteria of the
ANOVA, were analyzed using Kruskal-Wallis test, and a Wilcoxon’s test for multiple pairwise
comparison of the groups. For parameters including replicate measurements from the individ-
ual tanks, a nested ANOVA was fit using a mixed effects model with tank treated as a random
effect. Normal distribution, bias and homoscedasticity of the model residuals were checked,
and models were fitted on z-normalized data where necessary. Post-hoc group comparison
was performed on least-square means adjusting for multiple comparisons.
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Statistical analyses of data from histopathological evaluation were performed using IBM
SPSS Statistics 22 (Released 2013; IBM Corp., NY, USA), employing Pearson’s X2 (level of con-
fidence 95%) for pairwise comparison of group mean scores.
Results are presented as means ± SD of all measurements. Statistical significance compared
to the control group (EQ 0) is denoted with � p<0.05.
Data processing and statistical comparison of liver global metabolomic and proteomic pro-
files was performed using the Qlucore Omics Explorer version 3.1 (Qlucore AB, Lund, Swe-
den). Original scale raw area counts of all biochemicals and proteins were mean centered and
log2 transformed. The data were analyzed using one-way ANOVA followed by planned con-
trasts, comparing the liver metabolite and protein profiles of each exposure group to the livers
of unexposed animals. For statistical analyses, a p-values of p<0.05 was used as significance
cut-off and multiple test corrected p-values were calculated and reported. The data were fur-
ther explored using unsupervised principal component analysis and hierarchical cluster
analysis.
For a general biological pathway analysis of biochemical, Kyoto Encyclopedia of Genes and
Genomes (KEGG) accession numbers were determined for metabolites whose abundances
were significantly altered when compared to the control (EQ 0), and subsequently imported
into the Ingenuity Pathway Analysis software suite (IPA; Quiagen, CA, USA). In order to
interpret the proteomic data obtained from salmon livers, mammalian orthologs of Salmo
salar UniProt accession numbers were determined and uploaded to IPA. Consistent with the
metabolomics pathway analysis, only proteins significantly altered in comparison to EQ 0
were included into the analyses. IPA Core Analyses were performed on both successfully
mapped metabolites and proteins using default settings. For a concomitant interpretation of
the multi-omics dataset, an IPA Comparison Analysis was performed followed by targeted
upstream analyses as described in Rasinger et al. [27].
Benchmark dose assessment
Benchmark dose (BMD) analyses were conducted according to the benchmark dose technical
guidance by the European Food Safety Authority (EFSA) [15,28]. For continuous data, two
families of (nested) models; the exponential and Hill models, were fit on individual data using
the EFSA BMD platform (Proast, version 64.16; https://shiny-efsa.openanalytics.eu/app/bmd).
Ordinal data from histology were transformed into quantal data and the default set of models
[28] was fit on individual data using the EFSA BMD software (Proast, version 61.3) locally run
in R.
Selection of models was based on the Akaike information criterion (AIC). A default value
of 2 units difference between AICs is considered as the critical value by the EFSA [28]. BMD
models were accepted when the AIC of the model was lower than the AIC of the null model
(no dose response) -2 (AIC<AICnull-2), and the model with lowest AIC (AICmin) was lower
than the AIC of the full model +2 (AICmin<AICfull+2) [28]. As model averaging is recom-
mended as the preferred method for calculating the BMD confidence interval, model averag-
ing was performed for those data sets (quantal data: histology parameters) where this option
was available in the current publicly version of Proast. For data sets were no averaging option
was available (continuous data: plasma and blood parameters), the best model based on AIC
was used as described by the EFSA [28]. For continuous nested data, two models (model 3 and
5) were considered from the exponential and hill model families, and from these the model
with the lowest AIC was selected for calculating the BMD 90% confidence interval; the lower
bound is reported as BMDL and the upper bound as BMDU. The confidence intervals for the
BMD for nested models were estimated including bootstrap with standard 200 Bootstraps. The
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BMD is defined as the dose that corresponds with a specified estimated change in response
compared with the modelled background response. The BMR (benchmark response) is the
estimated response corresponding with the BMD of interest. A default of BMR of 5% change
was used as starting point for analyses for continuous data (BMDL05). However, where a wide
BMD confidence interval (BMDU/BMDL) indicated poor precision of the estimate, the BMR
was increased as described in the EFSA technical guidance document [28], and the BDML for
BMRs of 10 or 20% changes were considered (BMDL10 and BMDL20, respectively) for plasma
enzymes or adaptive responses (biomarkers of exposure). For quantal and ordinal data (histol-
ogy) the default BMR was defined as a specified increase in incidence over background, and
BMR of 10% (extra risk; BMDL10) was used as described by the EFSA [28].
Results
Feed intake, growth and body composition
After 90 days of dietary exposure to graded levels of EQ no mortality or gross signs of toxic
responses were observed in any of the experimental groups. No significant effects on feed
intake and growth performance were observed at doses up to EQ 3. However, exposure to die-
tary levels above this level, i.e. EQ 4 and EQ 5, significantly (p<0.05) reduced feed consump-
tion (Table 3). Hence, fish fed EQ 4 and EQ 5 displayed poor growth performance, as
indicated by a feed intake dependent reduction in specific growth rate, condition factor, and
final body weight when compared to fish from the control group (EQ 0). Concomitant to
lower body weight, organ masses of heart, liver and spleen were significantly decreased in fish
of the EQ 5 group, but not when normalized to body weight (cardio-, hepato- and spleenoso-
matic index, respectively).Thus, no treatment-related effects on organ weights were observed.
The proximate body composition of the fish was assessed through measurement of crude
protein, crude lipid, total ash and dry matter in whole fish, as well as the lipid content of the
muscle. Total protein content of whole fish homogenates was between 17.3 ± 0.6 (EQ 0) and
18.0 ± 1.0 (EQ 3) % ww, and was not affected by dietary EQ exposure of up to 40.0 ± 9.6 mg/
kg BW/ day (EQ 5). Meanwhile, fish fed EQ 4 and EQ 5 had significantly (p<0.05) reduced
levels of total body fat, total lipid content in muscle and total body dry matter, reflecting the
lower growth rate. Although not affecting lipid content in the fillet, fish fed EQ 3 had an overall
reduction in whole body fat, which could not be explained by reduced feed intake.
Tissue accumulation of ethoxyquin (EQ) and ethoxyquin dimer (EQDM)
Despite the gradually reduced feed intake and growth in EQ 4 and EQ 5, there was a dose-depen-
dent whole body accumulation of EQ and EQDM (S1 Table). The concentration of EQ relative to
the concentration of EQDM increased with increasing EQ exposure in whole fish. Similarly, there
was a dose-dependent increase of EQ and EQDM in muscle; however, the concentration of EQ
relative to the concentration of EQDM peaked at EQ 3 and decreased for EQ 4 and EQ 5.
Liver metabolomic profiling and pathway analysis
In a search for the underlying mode of action of the biological effects of EQ, an in depth meta-
bolic screening was performed on liver tissue. A total of 498 named biochemicals were
detected, of which 371 were significantly (p<0.05, ANOVA) affected by the treatment. Because
of the potential bias resulting from the significantly reduced feed intake in animals exposed to
doses above EQ 3, namely EQ 4 and EQ 5, were excluded from further analyses, yielding a
total of 192 metabolites (38, 60 and 152 metabolites in EQ 1, EQ 2 and EQ 3, respectively, as
compared to EQ 0), which were directly affected (p<0.05, ANOVA) by EQ treatment.
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Global liver metabolite profiles of fish exposed to graded levels of EQ were examined
through unsupervised PCA and HCA. The overall percentage of explained variance of the first
three components was low (52%). However, the PCA of liver metabolomic data revealed that
the metabolite profile of fish exposed to doses including EQ 0, EQ 1 and EQ 2 formed an over-
lapping population that clearly separated from fish exposed to EQ 3 along component 1 (Fig
1A). HCA revealed separation based on the dose of EQ with control and lower doses of EQ
(EQ 0, EQ 1 and EQ 2) grouped as metabolically similar (Fig 1B; left side of the panel). Liver
metabolite profiles of fish exposed to EQ 3 formed a separate cluster (Fig 1B; right side of the
panel).
Abundance of metabolites significantly altered compared to the control revealed metabolic
responses following exposure to dietary EQ higher than EQ 2 with 85 metabolites that were
Table 3. Growth parameters, feed intake, exposure estimation, survival, proximate body composition and organ weights of Atlantic salmon (Salmo salar L.)
exposed to graded levels of EQ through their diet for 90 days.
Dietary treatment
Growth parameters EQ 0 EQ 1 EQ 2 EQ 3 EQ 4 EQ 5 P-values
Final length (cm) 36.3 ± 3.5 37.0 ± 3.6 37.6 ± 3.3 37.9 ± 3.0 34.4 ± 3.1 29.4 ± 3.2� < .0001
Final body weight (g) 716.3 ± 234.5 728.1 ± 222.9 784.5 ± 197.2 756.7 ± 190.7 537.2 ± 155.5� 301.5 ± 111.5� < .0001
Body weight gain (g) 454.2 ± 234.5 467.5 ± 222.4 515.3 ± 197.4 493.9 ± 190.6 275.8 ± 155.4� 37.61 ± 111.7� < .0001
Specific growth rate (%�day-1) 1.1 ± 0.3 1.1 ± 0.3 1.2 ± 0.3 1.1 ± 0.3 0.8 ± 0.3� 0.1 ± 0.4� < .0001
Condition factor (g/cm3) 1.5 ± 0.1 1.4 ± 0.1 1.4 ± 0.1 1.4 ± 0.1 1.3 ± 0.1� 1.1 ± 0.1� < .0001
Mean daily feed intake (g�fish-1)a 4.9 ± 0.1 4.6 ± 0.6 5.1 ± 0.3 4.4 ± 0.4 2.9 ± 0.1� 1.1 ± 0.3� < .0001
Mean total feed intake (g�fish-1)b 435.9 ± 4.0 407.4 ± 50.7 452.6 ± 25.5 397.6 ± 32.5 255.0 ± 6.2� 100.0 ± 24.4� < .001
Feed conversion rate (�fish-1) 1.0 ± 0.2 0.9 ± 0.1 0.9 ± 0.1 0.8 ± 0.1 0.9 ± 0.1 4.0 ± 3.3 0.072
Total EQ consumed (mg�fish-1) 0.205 ± 0.002 17 ± 2 54 ± 3 466 ± 38� 1016 ± 25� 966 ± 236� < .001
Estimated daily EQ exposure
(mg�kg BW-1�day-1)c
0.0049 ± 0.0002 0.41 ± 0.05 1.22 ± 0.04 11 ± 1� 30 ± 2� 40 ± 10� < .001
Survival (%) 100 100 100 100 100 100
Proximate body composition whole fish (% ww)
Crude protein (N�6.25) 17.3 ± 0.6 18.0 ± 0.0 17.7 ± 0.6 18.0 ± 1.0 17.7 ± 0.6 17.3 ± 0.6 0.643
Crude lipid 15.2 ± 0.4 14.1 ± 0.2 14.1 ± 0.5 13.3 ± 0.4� 11.0 ± 0.4� 8.7 ± 1.3� < .001
Ash 1.8 ± 0.2 1.8 ± 0.2 2.0 ± 0.2 1.8 ± 0.1 1.9 ± 0.1 2.1 ± 0.1 0.207
Dry matter 34.0 ± 1.4 33.3 ± 0.7 33.9 ± 1.6 33.3 ± 0.6 30.0 ± 0.1� 27.8 ± 1.1� < .001
Crude lipid muscle 4.1 ± 1.0 3.5 ± 0.1 3.7 ± 0.7 4.0 ± 0.4 2.7 ± 0.1� 1.8 ± 0.7� < .01
Organ weights
Heart (g) 0.8 ± 0.3 0.8 ± 0.2 0.9 ± 0.2 0.8 ± 0.2 0.6 ± 0.2 0.4 ± 0.1� < .001
Cardiosomatic index (�100) 0.12 ± 0.01 0.10 ± 0.01 0.11 ± 0.01 0.10 ± 0.01 0.11 ± 0.01 0.12 ± 0.02 0.108
Liver (g) 8.0 ± 2.9 7.8 ± 2.4 8.8 ± 2.2 8.2 ± 2.5 6.7 ± 2.0 3.2 ± 1.3� < .001
Hepatosomatic index (�100) 1.05 ± 0.10 1.02 ± 0.08 1.08 ± 0.08 1.08 ± 0.12 1.16 ± 0.10 1.01 ± 0.20 0.102
Spleen (g) 0.6 ± 0.2 0.6 ± 0.3 0.6 ± 0.2 0.6 ± 0.3 0.5 ± 0.1 0.2 ± 0.1� < .01
Spleen somatic index (�100) 0.08 ± 0.02 0.08 ± 0.02 0.08 ± 0.01 0.08 ± 0.02 0.09 ± 0.03 0.07 ± 0.02 0.067
Measurements performed on tank pooled samples or tank means (n = 3/group) were analyzed performing one-way ANOVA and Tukey’s test for multiple comparison
of group means. For parameters including replicate measurements from the individual tanks, a nested ANOVA was fit using a mixed effects model (n = 25–30) with
tank treated as a random effect, and post-hoc comparison of least-square group means adjusting for multiple comparisons. Results are presented as means ± SD of all
measurements.
� p<0.05, compared to the control (EQ 0).
a Daily feed intake recorded per tank divided by number of fish.
b Sum of daily feed intake per fish
c Calculated from daily feed intake per fish and interpolated body weight per fish. Abbreviation: BW, Body weight.
https://doi.org/10.1371/journal.pone.0211128.t003
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only affected after exposure to EQ 3 (S4 Table). These responses were most notably associated
with liver energy metabolism, redox- homeostasis and purine/pyrimidine metabolism.
Energy metabolism. The in-depth metabolic screening revealed marked changes in sev-
eral pathways related to energy metabolism. Altered metabolite profiles related to hepatic lipid
metabolism were characterized by a decrease in diacylglycerol (e.g., palmitoleoyl-oleoyl-glyc-
erol (16:1/18:1)) and monoacylglycerol species (e.g., 1-palmitoleoylglycerol (16:1); Fig 2). Also,
significantly lower levels of long-chain fatty acids (e.g., stearate (18:0)) and polyunsaturated
fatty acids (e.g., omega-3 arachidonate (20:4n3)) were noted. A decrease in carnitine-, and
concomitant increase in acetyl-CoA levels suggested increased beta-oxidation rates in livers of
fish exposed to EQ 3 compared to EQ 0 (Fig 2).
Fig 1. Principal component analysis (PCA) and hierarchical clustering analysis (HCA) of 192 significantly
regulated (p<0.05, ANOVA) metabolites in livers of Atlantic salmon (Salmo salar L.) exposed to graded levels of
ethoxyquin (EQ) through their diet for 90 days. Differential analysis (ANOVA), PCA (A) and HCA (B) were
performed using the Qlucore omics-explorer. The heatmap (B) represents the concentrations of significantly affected
metabolites within each measured sample (represented in the columns). Yellow bars indicate higher concentrations of
a metabolite, while blue bars indicate lower concentrations of a metabolite, on a scale from -2 to 2, where 1 unit is
equal to a variance of 1 from the mean. See S2 Table for a complete overview of individual metabolites.
https://doi.org/10.1371/journal.pone.0211128.g001
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Furthermore, metabolic pathways involved in glucose metabolism and energy generation
were affected by the exposure to EQ. EQ treatment increased the levels of glycolytic intermedi-
ates glucose 6-phosphate and fructose 6-phosphate (Fig 3A and 3B), and caused a dose-depen-
dent decrease in hepatic creatinine (sig. >EQ 2; Fig 3A). In addition, EQ treatment resulted in
altered levels of pentose phosphate pathway biochemicals: 6-phosphogluconate levels were
decreased in a dose-dependent manner (significantly decreased following 90 days exposure to
levels above EQ 1), while ribose-1-phosphate levels were elevated. At the same time, lower lev-
els of the pentose sugars ribitol and arabitol/xylitol were observed with increasing concentra-
tions of EQ.
Liver redox-homeostasis. The glutathione system represents a major cellular redox buffer
that significantly contributes to the maintenance of the reduced intracellular milieu and,
hence, to the anti-oxidative capacity of cells. Ninety days of dietary exposure to graded levels
of EQ caused a substantial increase in the total glutathione pool (both reduced and oxidized)
in livers of Atlantic salmon. The levels of reduced glutathione (GSH) were elevated in a dose-
dependent manner following EQ treatment and to the higher degree than the levels of oxidized
species (GSSG) (Fig 4A). Cysteine, the limiting factor in GSH biosynthesis, is acquired by cells
as cystine (cysteine disulfide) or synthesized from methionine through the transmethylation
and transsulfuration pathways. Notably, while hepatic cysteine levels (S3 Table) were not
affected by the EQ treatment, levels of cystine were significantly reduced (Fig 4A). Concomi-
tantly, altered levels of metabolites involved in transmethylation and transsulfuration pathways
(Fig 4B), including reduced levels of methionine precursors, as well as S-methylcysteine and
N-methyltaurine (Fig 4A), and increase in homocysteine and S-adenosylhomocysteine (SAH)
and taurine (Fig 4A), were suggestive of increased utilization of these substrates to support
GSH biosynthesis. These changes were accompanied by an increase in gamma-glutamyl
amino acids (e.g., gamma-glutamylcysteine, gamma-glutamylleucine), which are formed when
the enzyme gamma-glutamyl transpeptidase (GGT) transfers the gamma-glutamyl moiety
from glutathione to an acceptor amino acid, as well as a concentration-dependent increase in
5-oxoproline and cysteinylglycine (Fig 4A). The levels of ophthalmate were significantly
increased following exposure to EQ 3, while both alpha- and gamma-tocopherol significantly
decreased. Ophthalmate is an endogenous analogue of GSH, which is considered a marker of
GSH consumption under oxidative stress conditions. Moreover, a dose-dependent elevation
in the levels of dihydroxy fatty acid 9,10-DiHOME (Fig 2), significantly increased after expo-
sure to EQ 3, was observed. As dihydroxy fatty acids are oxidation products derived from
essential polyunsaturated fatty acids, elevated levels of DiHOME fatty acids, derived from lino-
leic acid (18:2n-6), are reflective of hepatic oxidative stress. Thus, the observed treatment-
related changes in salmon liver metabolites reflected increased utilization of glutathione and a
compensatory induction of redox capacity, indicating a perturbation of liver redox-homeosta-
sis and presence of oxidative stress.
Purine and pyrimidine metabolism. Treatment related alterations in purine and pyrimi-
dine metabolism were observed after dietary treatment to EQ. A number of purine and pyrim-
idine intermediates showed changes after exposure to increasing concentrations of EQ (Fig
Fig 2. Heat map of significantly altered metabolites (ANOVA, p<0.05) belonging to the “lipid” super pathway in
livers of Atlantic salmon (Salmo salar L.) exposed to graded levels of ethoxyquin (EQ) through their diet for 90
days. Scaled intensity means were used to calculate log2 fold changes in the individual exposure groups compared to
unexposed control animals (EQ 0). Significance of change was analyzed through pairwise comparisons between the
individual exposure groups and the control, with colors denoting a significantly increased (yellow) or decreased (blue)
levels compared to the control. See S4 Table for a complete overview of individual metabolites.
https://doi.org/10.1371/journal.pone.0211128.g002
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5A). The concentration of purine and pyrimidine are dependent on the equilibrium between
both de novo synthesis and release from salvage pathways, and the rate of catabolism (Fig 5B).
The levels of adenine were higher when comparing samples from EQ-exposed animals to con-
trols, and were detectable above exposure to EQ 0 (Fig 5A). Orotate and orotidine containing
pyrimidines were decreased above exposure to EQ 1, guanine containing purines along with
Fig 3. Alterations in liver creatinine levels and carbohydrate metabolism in livers of Atlantic salmon (Salmo salar
L.) exposed to graded levels of ethoxyquin (EQ) through their diet for 90 days. (A) Metabolites displaying
differential expression (p<0.05, ANOVA) were grouped according to subpathway annotations. Scaled intensity means
were used to calculate log2 fold changes in the individual exposure groups compared to unexposed control animals
(EQ 0). Significance of change was analyzed through pairwise comparisons between the individual exposure groups
and the control, with colors denoting a significantly (p<0.05) increased (yellow) or decreased (blue) levels compared to
the control. (B) Overview of selected significantly affected carbohydrate metabolites within the pathways of
glycogenolysis, glycogenolysis and the pentose phosphate pathway. Metabolites significantly (p<0.05) affected by the
increasing EQ levels are denoted with yellow (increase) or blue (decrease) arrows. See S4 Table for a complete overview
of individual metabolites.
https://doi.org/10.1371/journal.pone.0211128.g003
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cytidine containing pyrimidines were increased above exposure to EQ 1, while uracil contain-
ing pyrimidines showed a less consistent response with both increased and decreased levels for
the different compounds.
Fig 4. Changes in redox homeostasis in livers of Atlantic salmon (Salmo salar L.) exposed to graded levels of
ethoxyquin (EQ) through their diet for 90 days. (A) Metabolites displaying differential expression (p<0.05,
ANOVA) were grouped according to subpathway annotations. Scaled intensity means were used to calculate log2 fold
changes in the individual exposure groups compared to unexposed control animals (EQ 0). Significance of change was
analyzed through pairwise comparisons between the individual exposure groups and the control, with colors denoting
a significantly (p<0.05) increased (yellow) or decreased (blue) levels compared to the control. (B) Overview of selected
treatment affected metabolites within the cysteine and glutathione metabolic pathways. Metabolites significantly
(p<0.05) affected by the increasing EQ levels are denoted with yellow (increase) or blue (decrease) arrows. See S4
Table for a complete overview of individual metabolites.
https://doi.org/10.1371/journal.pone.0211128.g004
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Liver proteomic profiling
In order to further investigate potential molecular mechanisms underlying the observed
effects of dietary EQ exposure on hepatic metabolites, proteomic profiling was performed
on liver sections of fish (n = 3/group) fed the EQ 0, EQ 1, EQ 2 and EQ 3 diet, respectively. A
total of 3394 proteins were detected, of which 287 were significantly (p<0.05, ANOVA) affected
by the treatment. Post hoc analysis using planned contrasts revealed that EQ 1, EQ 2 and EQ 3
induced significant (p<0.05) changes in the abundance of 57, 80 and 164 proteins, respectively.
Global liver proteome profiles of fish exposed to graded levels of EQ were examined
through unsupervised principal component analysis (PCA) and hierarchical clustering analysis
Fig 5. Alterations in purine and pyrimidine metabolism in livers of Atlantic salmon (Salmo salar L.) exposed to
graded levels of ethoxyquin (EQ) through their diet for 90 days. (A) Metabolites displaying differential expression
(p<0.05, ANOVA) were grouped according to subpathway annotations. Scaled intensity means were used to calculate
log2 fold changes in the individual exposure groups compared to unexposed control animals (EQ 0). Significance of
change was analyzed through pairwise comparisons between the individual exposure groups and the control, with
colors denoting a significantly (p<0.05) increased (yellow) or decreased (blue) levels compared to the control. See S4
Table for a complete overview of individual metabolites. (B) Overview of nucleotide metabolites within the pathways
of nucleotide synthesis, salvage, and catabolism.
https://doi.org/10.1371/journal.pone.0211128.g005
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(HCA). The overall percentage of explained variance of the first three components was 74%
and in accordance with the metabolite data revealed a clear separation between EQ 3 and the
exposure groups based on the lower doses of EQ (EQ 0, EQ 1 and EQ 2) along component 1
(Fig 6A).
HCA revealed a similar and more clearly resolved separation of the exposure groups based
on the dose of EQ (Fig 6B). Liver protein profiles of fish exposed to EQ 3 formed a separate
Fig 6. Principal component analysis (PCA) and hierarchical clustering (HC) of 287 significantly regulated
(p<0.05, ANOVA) proteins in livers of Atlantic salmon (Salmo salar L.) exposed to graded levels of ethoxyquin
(EQ) through their diet for 90 days. Differential analysis (ANOVA), PCA (A) and HC (B) were performed using the
Qlucore omics-explorer. The heatmap (B) represents the concentrations of significantly regulated proteins within each
measured sample (represented in the columns). Yellow bars indicate higher concentrations of a protein, while blue
bars indicate lower concentrations of a protein, on a scale from -2 to 2, where 1 unit is equal to a variance of 1 from the
mean. See S9 Table for a complete overview of individual proteins.
https://doi.org/10.1371/journal.pone.0211128.g006
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cluster from control and lower doses of EQ (EQ 0, EQ 1 and EQ 2). Unlike the metabolite
data, the proteomic data also allowed for a clear distinction between EQ 0, EQ 1 and EQ 2.
Grouping the significantly regulated proteins according to their biological functions re-
vealed that proteins were preferentially associated with metabolic process [GO:0008152], carbo-
hydrate metabolic process [GO:0005975], cell redox homeostasis [GO:0045454], translation
[GO:0006412], glycogen biosynthetic process [GO:0005978], intracellular protein transport
[GO:0006886], protein folding [GO:0006457], glutathione biosynthetic process [GO:0006750],
L-phenylalanine catabolic process [GO:0006559] and glycolytic process [GO:0006096] (Fig 7A).
In terms of molecular functions, ATP binding [GO:0005524], zinc ion binding
[GO:0008270], RNA binding [GO:0003723], metal ion binding [GO:0046872], GTPase activity
[GO:0003924], heme binding [GO:0020037], oxidoreductase activity [GO:0016491], GTP
binding [GO:0005525], transferase activity [GO:0016740] and DNA binding [GO:0003677]
were the top 10 affected molecular functions (Fig 7B). A comprehensive overview of all gene
ontology terms affected by EQ exposure is provided in S8 Table.
Multi-omics pathway analysis
The Ingenuity Pathway Analysis (IPA) platform was used with default settings to group signifi-
cantly affected metabolites and proteins into larger functional categories (S5A–S5D Table and
S10A–S10D Table, respectively). Integration of data from proteomic and metabolomic data in a
comparative analysis revealed distinct and overlapping dose-dependent responses on protein
and metabolite level (Fig 8). Comparative analysis of “Canonical pathways” annotations from
differentially expressed proteins and altered metabolites confirmed an overlap of a number of
enriched pathways, consistently highlighting “NRF2-mediated Oxidative stress Response”,
“Glutathione Redox Reactions I”, “Glycolysis”, “Glutathione-mediated detoxification”, “Vita-
min C Transport”, “Arsenate detoxification (Glutaredoxin)”, Phenylalanine Degradation (Aero-
bic)”, “Xenobiotic Metabolism Signaling”, “Pentose Phosphate Pathway”, “Pentose Phosphate
Pathway (Non-oxidative Branch)”, LPS/IL-1 Mediated Inhibition of RXR Function” and “Aryl
Hydrocarbon Receptor Signaling” as the 10 most affected pathways. Furthermore, the pathway
“Purine Nucleotides De Novo Biosynthesis” was consistently associated with EQ-induced dose-
dependent responses on metabolite and protein level, while effects on “Pyrimidine Ribonucleo-
tides De Novo Biosynthesis”, “Uridine-5’-phosphate Biosynthesis” and “Salvage Pathways of
Pyrimidine Ribonucleotides” were not evident on protein level (Fig 8A).
Causal network analysis of protein expression data, in which the direction of changes was
taken into account, highlighted an induction of the “NRF2-mediated Oxidative stress
response” at a dose of EQ 3 (z-scores� 1), and a dose-dependent inhibition of “PPARa/RXRa
activation” at doses above EQ 1 (z-scores� -1) from changes induced in liver proteins (Fig
8B). These findings were further investigated through upstream analyses in IPA, which pre-
dicted a dose-dependent activation of both transcription factors NFE2L2 and PPARA from a
significant overlap of EQ-induced changes in proteomic profiles with known responses com-
piled in the Ingenuity Knowledge Base (Fig 8C).
The full data-set including metabolites and proteins in each canonical pathway, as well as a
complete list of predicted upstream regulators are presented in S5A and S10A Tables, and S5D
and S10D Tables, respectively.
Hematology and plasma biochemistry
In order to assess the general health status of the fish as well as the effects of increasing dietary
EQ on the immune system, and kidney and spleen as the hematopoietic centers, the number
of RBC, Hct, Hb concentration and lysozyme activities were determined, and a differential
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Fig 7. Gene ontology analysis of significantly regulated (p<0.05, ANOVA) proteins in livers of Atlantic salmon (Salmo
salar L.) exposed to graded levels of ethoxyquin (EQ) through their diet for 90 days. Proteins displaying differential
expression (p<0.05, ANOVA) were grouped into the gene ontology categories biological processes (A) and molecular
functions (B). See S7 Table for a complete overview of individual proteins.
https://doi.org/10.1371/journal.pone.0211128.g007
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blood cell count was performed (S12 Table). There were no differences between the groups for
any of the above listed parameters.
Plasma biochemical markers of organ function were measured as albumin, ALT, AST, bili-
rubin, bile acids, total protein, creatinine, Na+, K+, Ca2+, Cl-, osmolality and lysozyme activity
(Table 4). Ninety days of dietary exposure to graded levels of EQ led to a dose-dependent
decrease of plasma creatinine levels where fish exposed to doses above EQ 2 (12.20 ± 2.53
μmol/L) displayed significantly lower levels compared to the Control (22.13 ± 5.62 μmol/L,
45% decrease; p<0.01). Plasma bile acid concentrations showed a 2.8-fold increase (p<0.05) in
animals exposed to the lowest dose (EQ 1; 41 mg/kg feed) when compared to animals with no
EQ added to the diets, and further appeared to be inversely related to dietary EQ exposure.
Other effects observed were lower levels of total protein (p<0.05), and the liver enzymes
ALT and AST in plasma of fish exposed to the highest dose of EQ (EQ 5; 9666 mg EQ/kg feed)
during 90 days compared to the control or the two lowest doses (EQ 1 and EQ 2), respectively.
Concomitantly, the concentrations of bilirubin in plasma of fish exposed to doses above EQ 3
(EQ 4: p = 0.080 and EQ 5: p = 0.094) were elevated. None of these plasma markers were
Fig 8. Canonical pathway and upstream regulator analyses of metabolites and proteins in Atlantic salmon (Salmo salar L.)
exposed to graded levels of ethoxyquin (EQ) through their diet for 90 days. (A) Significantly regulated (p<0.05, ANOVA)
metabolites and proteins in liver subjected to Ingenuity Pathway Analysis (IPA). Statistical significance of overrepresentation of
metabolites and proteins in different “canonical pathways” is shown as a heat-map. The top 50 of only selected pathways that
obtained a significant (p<0.05, Fisher’s exact test) enrichment score (-log10 p-value) in at least one of the exposure conditions and
were associated with at least two molecules are shown. Scores above the cut-off (1.3) are displayed by a color gradient. Scores below
the cut off value are displayed as white boxes. Matching expression patterns of proteins significantly affected in salmon livers after 90
days dietary EQ treatment identified activation (orange) or inhibition (blue) of two canonical pathways (B) and highlighted an
activation (orange) of NFE2L2 and PPARA as likely affected upstream regulators (C) independent of the overlap p-value using the
activation z-score. The full data-set including metabolites and proteins in each pathway, the complete list of significant pathways as
well as a complete list of predicted upstream regulators are presented in S5A and S10A Tables, and S5D and S10D Tables,
respectively.
https://doi.org/10.1371/journal.pone.0211128.g008
Table 4. Plasma biochemical markers of organ function and stress of Atlantic salmon (Salmo salar L.) exposed to graded levels of ethoxyquin (EQ) through their
diet for 90 days.
Dietary treatment
Markers of organ function EQ 0 EQ 1 EQ 2 EQ 3 EQ 4 EQ 5 P-values
Albumin (umol/l) 344.79 ± 30.02 326.25 ± 24.49 347.29 ± 19.04 362.88 ± 31.21 350.07 ± 35.00 286.94 ± 59.73 < .05
ALT (U/l) 12.81 ± 9.92 14.24 ± 5.74 21.54 ± 13.09 18.84 ± 13.13 13.19 ± 9.25 3.60 ± 2.99 < .05
AST (U/l) 431.78 ± 106.55 459.85 ± 149.48 456.40 ± 85.51 412.63 ± 129.22 411.02 ± 165.32 266.68 ± 110.86 0.54
Bilirubin (umol/l) 1.60 ± 0.32 1.56 ± 0.49 1.41 ± 0.38 1.69 ± 0.33 2.05 ± 0.51 2.06 ± 0.28 < .01
Bile acids (umol/l) 1.80 ± 0.98 5.01 ± 4.14� 4.37 ± 3.81 2.85 ± 2.27 2.51 ± 1.23 1.57 ± 0.31 < .05
Total protein (g/l) 48.04 ± 4.64 45.84 ± 4.61 48.40 ± 3.21 48.17 ± 5.01 46.27 ± 5.23 36.68 ± 7.58� < .01
Creatinine (umol/l) 22.13 ± 5.62 19.35 ± 5.53 19.29 ± 4.47 12.20 ± 2.53� 9.57 ± 2.38� 8.64 ± 1.64� < .0001
Na+ 172.40 ± 3.38 172.20 ± 2.91 171.60 ± 2.17 173.07 ± 3.08 171.40 ± 3.11 172.40 ± 4.22 0.95
K+ 2.18 ± 0.90 2.25 ± 0.68 2.56 ± 0.98 2.07 ± 0.95 2.12 ± 0.60 1.85 ± 0.80 0.64
Ca2+ 1.75 ± 0.09 1.78 ± 0.05 1.74 ± 0.08 1.76 ± 0.05 1.76 ± 0.07 1.79 ± 0.11 0.71
Cl- 146.93 ± 2.46 147.87 ± 2.88 147.53 ± 1.77 148.13 ± 2.72 146.80 ± 2.27 147.07 ± 3.85 0.75
Osmolality (mOsmol/l) 349.27 ± 12.05 351.07 ± 8.04 350.00 ± 6.53 349.40 ± 9.97 349.33 ± 11.17 344.80 ± 11.55 0.93
Measurements performed on five replicate measurements from the individual tanks (n = 3/group). A nested ANOVA was fit using a mixed effects model with tank
treated as a random effect, and post-hoc comparison of least-square group means adjusting for multiple comparisons. Results are presented as means ± SD of all
measurements.
� p<0.05, compared to the control (EQ 0).
Abbreviations: ALT; Alanine aminotransferase. AST; Aspartate aminotransferase.
https://doi.org/10.1371/journal.pone.0211128.t004
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affected by dietary EQ treatment at lower doses. This observation may therefore be a direct
result of the general status of malnutrition associated with the reduced feed intake at doses
above EQ 3 rather than an effect induced by EQ. There were no differences in plasma electro-
lyte concentrations or osmolality between any of the groups.
Liver oxidative stress status
In order to assess the indications of oxidative stress and altered purine/pyrimidine metabolism
found in the metabolomics and proteomic screening, targeted analyses of biomarkers of oxida-
tion and oxidative DNA damage were performed. Following 90 days dietary exposure to EQ,
changes in hepatic redox homeostasis were noted (Table 5). A significant increase (<25%) in
hepatic TBARS concentrations was observed after 90 days exposure to doses above 118.8 mg/kg
feed (EQ 3; p<0.05), indicating increased rates of lipid peroxidation. Concomitantly, hepatic
vitamin E levels were significantly reduced (p<0.001). While alpha-tocopherol concentrations
significantly decreased (<30%; p<0.001) at doses above EQ 3 compared to the control
(2330.0 ± 277.8 mg alpha tocopherol/kg), hepatic gamma-tocopherol were already significantly
lower (<20%, p<0.05) after exposure to the lowest dose of EQ (41 mg EQ/kg feed). Moreover, a
substantial increase in the total hepatic glutathione pool was observed. Dietary EQ elevated the
levels of both GSH and, to a lower degree, GSSG in a dose-dependent manner (p<0.001 and
p<0.01, respectively). No significant changes were observed in DNA oxidation and oxidative
DNA damage as quantified by measurement of 8-oxo-dG formation and number of AP sites.
Gross pathology/histology
In kidney (Table 6), presence of higher number and intensity of pigmented macrophage aggre-
gates (PMA) was observed in fish exposed to the highest dose of EQ (EQ 5, p<0.05).
Table 5. Oxidative stress markers and markers for oxidative DNA damage in livers of Atlantic salmon (Salmo salar L) exposed to graded levels of ethoxyquin (EQ)
through their diet for 90 day.
Dietary treatment
EQ 0 EQ 1 EQ 2 EQ 3 EQ 4 EQ 5 P-values
Oxidative stress
GSH (μM) 2445 ± 350 3276 ± 664 3538 ± 613 4805 ± 675� 6431 ± 612� 6141 ± 1765� < .0001
GSSG (μM) 6 ± 1 7 ± 1 6 ± 1 9 ± 2 12 ± 2� 10 ± 2� < .01
GSH/GSSG 420 ± 46 491 ± 87 509 ± 97 557 ± 101 574 ± 125 666 ± 178 0.157
TBARS (nmol/g ww) 3.5 ± 0.3 3.5 ± 0.3 3.4 ± 0.1 4.4 ± 0.4� 5.2 ± 0.9� 4.7 ± 0.3� < .01
Vitamin E (mg/kg ww)
α-tocopherol 2330.0 ± 277.8 2336.7 ± 193.5 2053.3 ± 30.6 1633.3 ± 66.6� 1353.3 ± 121.0� 1193.3 ± 156.3� < .0001
γ-tocopherol 31.0 ± 7.0 24.7 ± 2.1� 23.3 ± 1.5� 15.9 ± 1.8� 13.1 ± 1.4� 12.3 ± 2.4� < .0001
Oxidative DNA damage
AP sites/10^5 bp 37.1 ± 4.4 40.0 ± 3.0 30.4 ± 0.4 27.7 ± 7.9 31.2 ± 8.8 32.9 ± 5.6 0.173
8-oxodG (nM)/DNA (μg/μl) 14.2 ± 1.7 14.1 ± 0.7 14.1 ± 0.7 14.1 ± 0.5 13.9 ± 0.8 15.9 ± 1.1 0.214
Measurements performed on tank pooled samples or tank means (n = 3/group) were analyzed performing one-way ANOVA and Tukey’s test for multiple comparison
of group means. For parameters including replicate measurements from the individual tanks (n = 25) a nested ANOVA was fit using a mixed effects model (nlme) with
tank treated as a random effect and post-hoc comparison of least-square group means adjusting for multiple comparisons. Results are presented as means ± SD of all
measurements.
� p<0.05, compared to the control (EQ 0).
Abbreviations: GSH; Glutathione (reduced), GSSG; Glutathione (oxidized), TBARS; Thiobarbituric acid reactive substances, AP; apurinic/apyrimidinic, bp; base pairs,
8-oxodG; 8-hydroxy-2’-deoxyguanosine.
https://doi.org/10.1371/journal.pone.0211128.t005
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Additional Pearl’s Prussian Blue staining of kidney sections verified absence of iron-derived
pigments. Thus, the increase in PMA did not appear to be associated to hemolysis (S1A and
S1B Fig). Some hyaline drops were observed in tubules, although the number of observed
drops was small and thus not considered pathological (S1C and S1D Fig).
The main histopathological finding in the splenic tissue was red pulp congestion and sub-
capsular hemorrhage in fish fed the highest dose of ethoxyquin (EQ 5, p<0.05; Table 6 and S2
Fig). However, some of the fish fed the lower EQ levels showed moderate congestion, suggest-
ing that changes observed in splenic tissue were likely not related to EQ treatment.
Histopathological evaluation of liver tissue revealed a marked reduction in the glycogen
and lipid storage along with an increase of dietary EQ concentrations. The decreased hepato-
cellular vacuolization, a visible reduction in hepatic energy stores, correlated with the reduced
feed intake in fish fed high levels of EQ (EQ 4 and EQ 5; Fig 9A). However, a significant
decrease in liver cytoplasmic vacuolization was also observed in fish receiving EQ 3 compared
to control animals, although this dose did not negatively affect feed consumption. Other
changes observed in the liver were mild inflammatory infiltrate (Fig 9B- left panel), mainly
lymphocytes, and moderate congestion (Fig 9B- right panel), although these findings seemed
casual and not treatment-related. The number of mitosis/apoptosis observed was normal and
did not differ between treatment groups.
Benchmark dose assessment
The BMDL assessment was performed on the estimated daily dose versus biological parameter
(Table 7). For fish fed the two highest feed concentrations (3985 and 9666 mg EQ/kg), a signif-
icant (p<0.05, ANOVA, Tukey’s-t) lower feed intake was observed compared the other expo-
sure groups. For biological parameters directly affected by reduced feed intake (growth, feed
conversion, organ index) BMDL assessment was performed with the first three exposure
groups (EQ 0- EQ 3), which did not differ in feed intake. As reduced growth performance is
generally considered an adverse effect, the default BMR of 5% was chosen, and a BMDL05 was
established at 0.8 mg EQ/kg BW/day for the condition-factor (k). No trend was observed for
changes between EQ 0 and EQ 3 for any of the other parameters (AllAIC>AICnull-2).
For blood and plasma parameters, that are less likely to be directly affected by reduced feed
intake (no starvation occurred) a BMDL was assessed including all exposure groups. Although
ANOVA did not detect significant effects for any of the hematological parameters, models
could be fit to Hct, HGB, MCV and MCH, with BMDL05 ranging between 1.1 (MCV) and 14.9
Table 6. Mean scores for the different histopathological parameters used to assess the kidney, spleen and liver damage in Atlantic salmon (Salmo salar L.) exposed
to graded levels of ethoxyquin (EQ) through their diet for 90 day.
Dietary treatment
Parameter assessed EQ 0 EQ 1 EQ 2 EQ 3 EQ 4 EQ 5
Kidney
Presence of pigmented macrophages aggregates (PMA) 0.3 ± 0.3 0.2 ± 0.2 0.2 ± 0.2 0.4 ± 0.4 0.4 ± 0.4 1.2 ± 1.2�
Spleen
Congestion and subcapsular hemorrhages 0.7 ± 0.7 0.2 ± 0.3 0.1 ± 0.2 1.0 ± 0.6 1.0 ± 0.5 1.6 ± 0.5�
Liver
Vacuolization in hepatocyte cytoplasm 2.1 ± 0.6 2.1 ± 0.6 2.2 ± 0.8 0.7 ± 0.4� 0.5 ± 0.3� 0.2 ± 0.2�
Scoring was performed in a double-blinded format. Results are presented as mean ± SD of 9 individually scored animals per experimental group.
Group mean scores were compared using Pearson’s X2 (level of confidence 95%).
� p<0.05. compared to the control (EQ 0).
https://doi.org/10.1371/journal.pone.0211128.t006
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(HGB) mg EQ/kg BW/day. Because the model fit for some of the plasma markers indicated a
poor precision of the estimates (as indicated by broad confidence intervals), the BMR was
adjusted to 10% above the modelled background response for AST and plasma total protein,
and a 20% was used for ALT, bilirubin, plasma albumin, and plasma creatinine. Of plasma
markers of physiological/metabolic effects, creatinine had the lowest BMDL20 (0.5 mg EQ/kg
BW/day). However, as creatinine levels directly correlate with energy turn-over, the observed
effect could be the results of reduced feed intake rather than effects of EQ. The lowest BMDL20
for plasma markers of adverse effects was therefore set for bilirubin with a BMDL20 of 5.5 mg
EQ/kg BW/day. Typical plasma markers of adverse effects on liver such as liver enzymes ALT
and AST had a BMDL20 of 14.5 mg EQ/kg BW/day and BMDL10 of 10.9 mg EQ/kg BW/day,
Fig 9. Histopathological findings in of Atlantic salmon (Salmo salar L.) exposed to graded levels of ethoxyquin (EQ)
through their diet for 90 days. Liver sections (5μm) showed reduced intracytoplasmic vacuolization along with the
increase in dietary content of EQ (A). H&E, scale bars: 50 μm. (B) Non-treatment related findings included lymphocytic-
type infiltrate (left panel, arrow) and hepatic congestion (right panel, asterisk). H&E, scale bars: 50 μm (left panel) and
100 μm (right panel).
https://doi.org/10.1371/journal.pone.0211128.g009
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respectively (Table 7). For liver TBARS, a measurement of formation of potentially toxic lipid
peroxidation products, a BMDL20 of 8.0 mg EQ/kg BW/day was established (Table 7).
Furthermore, changes in liver GSH and GSSG levels as well as liver vitamin E levels were
assessed. Changes in the liver oxidative defense systems are considered homeostatic responses
and were as such regarded as markers of exposure rather than markers of adverse effect. As
expected, as effect of exposure the BMDL20’s for these parameters were very low. With 0.0008
mg/ kg BW/day, liver GSSG levels had the lowest BMDL20 of the adaptive oxidative stress
responses. However, a very large BMDU/BMDL (> 20 000) indicated an unreliable estimate
(S16 Table). With a BMDU/BMDL of 5.4, alpha tocopherol in the liver showed the most reli-
able assessment for the liver adaptive responses and a BMDL20 of 1.7 mg EQ/kg BW/day was
Table 7. Benchmark doses (BMD), lower and upper 90% confidence interval (BMDL and BMDU, respectively) and No Observed (Adverse) Effect Level (NOAEL/
NOEL) for relevant responses in Atlantic salmon (Salmo salar L.) exposed to graded levels of ethoxyquin (EQ) through their diet for 90 day. Values are given in mg
EQ/kg BW/day estimated from feed intake.
BMD05 BMDL05 BMDU05 BMD10 BMDL10 BMDU10 BMD20 BMDL20 BMDU20 NOAEL (NOEL)
Endpoint ANOVA
Growth parameters (EQ 0 –EQ 3)
Condition
factor (k)
11.4 0.8 121.0 11
Hematological parameters (EQ 0 –EQ 5)
Hct 28.2 13.1 40.0
HGB 26.8 14.9 36.0
MCV 7.4 1.1 63.8
MCH 28.8 2.6 80.3
Biomarkers of liver function (EQ 0- EQ 5)
Bile acids none none none none none none 0.4
ALT 26.4 14.5 32.5 n.s. (30)
AST 25.8 10.9 29.3 n.s. (30)
Bilirubin 17.8 5.5 30.5 n.s. (11)
Albumin 45.1 41.5 49.7 30 (p = 0.058)
Total protein 31.6 28.7 33.6 30
Creatinine 2.0 0.5 9.2 1.2
Liver oxidative stress markers (EQ 0- EQ 5)
TBARS 8.0 2.3 13.1 1.2
Liver alpha-
tocopherol
4.6 1.7 9.2 1.2
Markers of oxidative DNA damage (EQ 0- EQ 5)
8-oxo-dG none none none n.s. (40)
AP sites none none none n.s. (40)
Histopathology (EQ 0- EQ 5)
Liver: Depletion of vacuoles 6.0 3.2 17.9 11
Kidney: Severe presence of pigmented
macrophage aggregates
38.4 36.7 39.3 30
Spleen: Severe congestion of spleen tissue 12.1 2.7 35.8 30
Taking the width of the 90% confidence intervals (BMDU/BMDL) into consideration, benchmark responses were set at the default of 5%, or adjusted to 10 or 20%. For
derivation of the critical BMDL, the width of the confidence interval was taken into account as an indicator of precision. The No-observed-(adverse)-effect-levels
(NOAEL/NOEL) was determined from statistical comparisons of responses in each predetermined dose group with the control group. Raw data and the Akaike
Information Criteria for all models assessed, as well as models for the critical endpoints included into the evaluation for the critical BMDL are available in S16 Table.
Abbreviations: Hct, Hematocrit; HGB, Hemoglobin; MCV, Mean corpuscular volume; MCH, Mean corpuscular hemoglobin; ALT, Alanine amino-transferase; AST,
Aspartate aminotransferase; TBARS, Thiobarbituric acid reactive substances; GSH, Reduced glutathione; GSSG, Oxidized glutathione; 8-oxo-dG, 8-hydroxy-2’-
deoxyguanosine; AP, apurinic/apyrimidinic.
https://doi.org/10.1371/journal.pone.0211128.t007
Toxicity of dietary ethoxyquin in Atlantic salmon
PLOS ONE | https://doi.org/10.1371/journal.pone.0211128 January 25, 2019 27 / 36
established. No trend was observed for the markers of oxidative damage (8-oxo-dG and AP
sites; AllAIC>AICnull-2).
For histology data a BMDL was derived from an average model constructed by averaging
all weighted-model results of the default set of models run. With 2.7 mg EQ/kg BW/day the
lowest BMDL10 was established for “Severe congestion of spleen tissue” (Table 7). However,
the BMDL10 of 3.2 mg EQ/kg BW/day “Severe depletion of intracytoplasmic vacuoles” in liver
was found the most reliable assessment (BMDU/BMDL: 5.5). A complete overview of the raw
data used for the analysis, all modelled parameters and the models included into the evaluation
of the critical BMDL, is provided in S14–S16 Tables.
Discussion
Ethoxyquin is widely used as an additive in ingredients and formulated feeds for farmed ani-
mals including Atlantic salmon. The toxic potential of EQ in salmon has yet to be addressed.
The present study investigated effects of dietary EQ in Atlantic salmon through a 90-day sub-
chronic dose-response study, using a dose range from 0 to 10 000 mg EQ/ kg complete feed.
Dietary exposure to EQ at concentrations above 1173 mg EQ/kg feed, namely EQ 4 (3985
mg EQ/kg) and EQ 5 (9666mg EQ/kg) significantly affected feed intake and growth perfor-
mance in Atlantic salmon (Table 3). Similar to our findings, Bohne et al. [5] found no effects
of dietary EQ on growth or feed intake in Atlantic salmon up to a concentration of 1800 mg/
kg feed, whereas diets containing a concentration of 15 000 mg/kg feed were rejected by the
fish. Since all animals included in the present study came from the same stock and were reared
under identical experimental conditions, the differences in feed intake and growth perfor-
mance can most likely be attributed to dietary EQ levels as the only variable factor. Previous
studies have reported inconsistent findings of the effects of dietary EQ exposure on growth
response. Improved growth, as observed by several studies on EQ in different animal species
[29,30,31,32], may likely be due to preserved nutritional quality of the diet under storage, espe-
cially prevention of lipid oxidation by EQ [29], which may affect palatability of aquafeed. On
the other hand, although preventing lipid oxidation in stored diets, inclusion of 200 mg EQ/kg
feed led to reduced growth in shrimp, which was associated with reduced feed intake and
altered feeding behavior [33]. Similarly, reduced growth rates in juvenile large yellow croaker
(Pseudosciaena crocea) after exposure to 1350 mg EQ/kg feed were associated with a trend in
decreased feed intake with increasing dietary EQ, although no significant effect was observed
[11].
As EQ is described to have a mercaptan like scent [10], inclusion of high levels of EQ may
have affected diet palatability due to its sensory properties. Indeed, fish receiving diets contain-
ing 3985 (EQ 4) and 9666 (EQ 5) mg EQ/kg consumed only 60% and 13% compared to the
feed intake of the control group (EQ 0) already during the first week indicating that poor palat-
ability prevented the fish from consuming the diet. Alternatively, altered feeding behavior at
higher doses could also be secondary to acute effects of EQ, e.g. due to organ damage caused
by EQ exposure. However, there were no mortalities linked to any dietary treatment during
the study.
Excluding EQ 4 and EQ 5 exposed fish and focusing on dietary groups with similar feed
intake, integration of data from proteomic and metabolomic screenings revealed distinct and
consistent EQ-induced responses in livers of salmon exposed to 119 (EQ 2) and 1173 (EQ 3)
mg EQ/kg feed compared to the control group (EQ 0); these were mainly related to changes in
energy metabolism, redox homeostasis and purine/pyrimidine metabolism. For other effects,
see S5A–S5C and S10A–S10C Tables. Observed alterations in the fatty acid metabolism, such
as e.g. reduced levels of diacylglycerols and carnitine, and elevated acetyl CoA (Fig 2),
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suggested increased fatty acid β-oxidation in fish exposed to EQ at doses higher than 1.22 mg/
kg BW/day (EQ 2). The indications from altered metabolite levels were further supported by
the bioinformatic pathway analysis of EQ-induced changes on the liver protein levels using
IPA, which predicted an activation of peroxisome proliferator-activated receptor alpha
(PPARα), the master regulator of hepatic fatty acid β-oxidation, from a significant overlap in
the response compared to known targets (Fig 8C), as well as (PPARα)/retinoid X receptor
alpha (RXRα) activation as an affected canonical pathway (Fig 8B). Furthermore, changes in
individual metabolite levels displayed an elevation of glucose 6-phosphate and reduced phos-
phoenolpyruvate, along with significant increases in other glycolytic intermediates (Fig 3A).
Consistently, functional annotations of altered protein levels in liver were preferentially related
to metabolic processes as well as carbohydrate metabolic processes (Fig 7A). The observed
changes may reflect a mobilization of hepatic glycogen stores but may also be due to a redirec-
tion of glucose to the pentose phosphate pathway, as revealed by the performed pathway analy-
sis (Fig 8A).
The pentose phosphate pathway utilizes glucose 6-phosphate to generate NADPH for bio-
synthetic reactions and Phase I metabolism of xenobiotics through the cytochrome P450 sys-
tem. Indeed, induction of CYP1A1 and CYP3A mRNA was affected by dietary EQ indicating
Phase I metabolism of EQ as shown by Bohne et al. [14]. The decrease in pentose sugars and
some of the pentose phosphate pathway intermediates may be indicative of a decrease in glu-
cose supply or increased pathway activity to support the demand for NADPH that can be used
to support detoxification reactions, which were consistently associated with the observed alter-
ations in metabolite and protein levels in livers of EQ exposed salmon in the present study (Fig
8A). Moreover, consistent with the effect of EQ treatment observed on plasma creatinine levels
(Table 4), hepatic creatinine levels decreased in a dose-dependent manner. Lowered plasma
creatinine levels are commonly used as biomarker for renal dysfunction, but may also reflect
declining hepatic functional capacity and alterations in hepatic energy metabolism. Taken
together, the results from metabolomic and proteomic screening indicated that an increased
energy expenditure in response to EQ exposure, perhaps due to the costs of detoxification or
tissue repair [34].
Organ damage resulting from EQ exposure has previously been described for many differ-
ent animals. High concentrations of EQ metabolites have been found in the liver of Atlantic
salmon fed graded levels of EQ [35]. Indeed, EQ readily accumulates in the liver, which was
shown to be a main target site of EQ-induced adverse effects in other species, as described in a
Scientific opinion on safety and efficacy of EQ for all animal species published by EFSA in
2015 [8]. In fish, reduced hepatosomatic indices were reported for large yellow croaker receiv-
ing 450 and 1350 mg EQ/kg feed for 10 weeks [11], while Saxena et al. [12] found that dietary
exposure to 200 and 400 mg EQ/kg feed for 16 days increased the hepatosomatic index in tur-
bot. Similar to previous findings in Atlantic salmon by Bohne et al. [14], in the present study
EQ did not affect liver, spleen or heart weights relative to body size after 90 days exposure with
the exception of fish exposed to EQ 5, which had a low feed intake throughout the study.
As seen from the histological evaluation of liver, kidney, and spleen in the present study,
liver seemed to be the main organ for EQ toxicity in Atlantic salmon. Despite the absence of
clear EQ-induced changes in relative liver weights, histological evaluation of liver sections in
the present study showed a dose-dependent decrease in intracytoplasmic vacuolization at
exposure to feed concentrations above 119 mg EQ/kg (EQ 2), which indicated a loss of cyto-
plasmic glycogen and/or lipid. While livertoxicity is more commonly associated with increased
hepatocellular vacuolization [36], the observed histopathological changes with a depletion of
hepatocellular vacuoles were consistent with the induction of lipid and carbohydrate catabolic
pathways in groups exposed to 119 (EQ 2) and 1173 (EQ 3) mg EQ/kg feed compared to the
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control group (EQ 0) as indicated from the results of the metabolomic/proteomic screening.
Elevated energy expenditure in response to dietary EQ exposure was further corroborated by
the observed dose-dependent decrease in lipid content in whole fish at doses above 119 mg
EQ/kg (EQ 2). Other changes observed in the liver were moderate congestion and mild inflam-
matory infiltrate (mainly lymphocytes; Fig 9B), although these findings seemed casual and not
treatment-related. The number of mitosis/apoptosis observed was within the normal range
and did not appear to be affected by the treatment, which does not seem to indicate increased
cytotoxicity by EQ as previously described in vitro [37].
The metabolomic and proteomic screening indicated changes associated with redox-
homeostasis mediated through increased utilization of glutathione (GSH). GSH is an impor-
tant endogenous antioxidant that participates both directly and indirectly in the scavenging of
reactive oxygen species (ROS). GSH may react directly with ROS with subsequent formation
of glutathionyl radicals, but is also an electron donor for antioxidant enzymes such as glutathi-
one peroxidase where GSH is oxidized to GSSG. To maintain the levels of reduced GSH for
continued antioxidant defense, a redox cycle is formed where GSSG is reduced back to GSH
by glutathione reductase using NADPH [38]. In line with previous evidence from a study in
mice [39], the canonical pathway analysis (Fig 8) of salmon liver metabolome and proteome
suggested that EQ activates the NRF2 (Nuclear factor erythroid 2-related factor 2) signaling
pathway, resulting, primarily, in an increase in the transcription of detoxifying enzymes such
as certain glutathione-S transferase (GSTs) isoenzymes or NAD(P)H: quinone oxidoreductase
1 (NQO1).
Quantitative analyses of GSH and GSSG (Table 5) confirmed increased concentrations of
GSH in livers of fish exposed to EQ at concentrations higher than 119 mg/kg feed (EQ 2),
while increased concentrations of GSSG were observed in fish exposed to concentrations
higher than 1173 mg EQ/kg feed (EQ 3). GSH is synthesized de novo via the SAM cycle and
the trans-sulfuration pathway from the amino acids cysteine, glutamate and glycine. The first
step is catalyzed by glutamate-cysteine ligase (GCL). Oxidative stress increases the GCL activ-
ity to produce more GSH [38,40,41]. Although a depletion of cellular GSH storage is more
commonly used as a marker for oxidative stress, the observed shift in the cellular redox equi-
librium may reflect compensatory induction of GSH biosynthesis and thus indicate a situation
of oxidative stress. Indeed, a dose-dependent depletion of vitamin E was seen for EQ doses
above 119 mg EQ/kg (EQ 2) for α-tocopherol and above 0.5 mg EQ/kg (EQ 0) for γ-tocoph-
erol. A consequence of reduced levels of vitamin E is a reduced capacity to protect against oxi-
dative damage to DNA, proteins and lipids. A common method of detecting oxidative damage
to lipids is by determining products of lipid peroxidation such as malondialdehyde (MDA)
using the TBARS assay [42]. Elevated levels of TBARS were found for EQ doses above 119 mg
EQ/kg (EQ 2) indicating increased levels of MDA, though the TBARS method has been criti-
cized for having low specificity for MDA detection [42]. Nevertheless, the findings were con-
sistent with other markers of oxidative stress.
MDA has the capacity to impair several physiological mechanisms of the human body
through its ability to react with molecules such as DNA and proteins. MDA can react with
DNA and form nucleic acid adducts and are associated with a variety of pathological events
[43]. In the metabolomic screening, alterations in the purine and pyrimidine metabolism were
found for all dietary inclusion levels of EQ for adenine (Fig 5A). These alterations in pyrimi-
dine and purine metabolism could imply an increased requirement for nucleotides for DNA
or RNA repair due to oxidative stress. The formation of 8-hydroxy-2’-deoxyguanosine (8-oxo-
dG) is considered a predominant DNA alteration in oxidative DNA damage [44]. Moreover,
DNA damage can manifest in the formation of apurinic or apyrimidinic (AP or abasic) sites.
EQ has been shown to induce chromosome aberrations including breaks, dicentrics, atypical
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translocated chromosomes and chromatid exchanges in vitro [37,45,46,47]. However, in the
present study no significant changes were observed in DNA oxidation in either of the two
included biomarkers of DNA damage (Table 5). On the other hand, adenine is also a precursor
of several intermediates involved in energy metabolism; ATP, FAD, NADH and NADPH.
However, the derived structures adenosine, AMP and ADP were not elevated in a dose-depen-
dent manner and thus appeared not-treatment related. Conversely, the mono- and di-phos-
porylated forms of guanine nucleotide (GTP), which also serves as an energy source for
protein synthesis and gluconeogenesis, were decreased at dose levels above EQ 1, but not for
EQ 5. Orotate, a precursor in the biosynthesis of pyrimidines, was elevated at doses above EQ
0, but no clear dose-related pattern could be seen for cytidine and uracil containing pyrimi-
dines. Taken together, these changes could be related to the direct effects of EQ on purine and
pyrimidine synthesis but might also be related to the altered activity of pentose phosphate
pathway (Fig 8A). Given the observed changes in purine/pyrimidine metabolism, independent
studies should address if these changes are due to genotoxic effects of EQ, increased cell prolif-
eration, changes in repair mechanism, or are secondary to alteration in pentose phosphate
pathway activity.
Benchmark dose assessment and derivation of a safe upper intake level
The benchmark dose (BMD) approach was used to characterize toxicity risk and derive a refer-
ence point for the upper level of intake of EQ for salmon. Using the experimental data to
model a dose-response relationship for an adverse outcome, low but detectable increases can
be used to determine the dose threshold for a toxic effect. When deriving a reference point, the
EFSA recommends to replace the traditionally used no-observed-adverse-effect level
(NOAEL) with the 90% lower confidence limit of the BMD model (BMDL) [15].
In addition to the histopathological findings, metabolomic and proteomic screenings and a
range of biomarkers were measured to evaluate the toxic mode of action for EQ. In 2017, the
EFSA published a new guidance document, in which the difference between adverse effect,
biomarkers of exposure or effect, and mode of action (MOA) were defined [48]. The use of
biomarkers of exposure in an adverse effect assessement should be assessed cautiously since
changes in biomarkers of effect do not necessarily reflect an adverse effect, but rather a result
of homeostatic regulation or adaptation [49]. This is particularly true for–omics data; although
useful for gaining new insights in mechanistic toxicology and generating hypotheses about dis-
ease pathways, their semi-quantitative nature calls for a conservative approach when using
them in assessing severity of effects [49]. For this reason, BMD modelling was not performed
for the–omics data. The use of biomarkers of effects that are related to EQ specific modes of
toxic actions and occur prior to the development of overall adverse effect, are however relavant
to use in assessing adverse effects in subchronic (30% of life time; 3 months) exposure studies.
The most significant responses observed in the present study were a perturbation of energy
metabolism, induction of oxidative stress and altered purine/pyrimidine metabolism. All
quantitative biomarkers, possibly representing an impairment of functional capacity (i.e. the
hematological parameters, biomarkers of liver function and the biomarkers of oxidative
stress), were subjected to BMD modelling. However, representing a manifestation of physio-
logical effects, effects on the growth response and the morphological changes observed in the
histopathological evaluation of spleen, kidney and liver in the present study were regarded the
most biologically relevant effects [48], and thus considered as critical endpoints for this study
(Table 7). Although the lowest BMDL was estimated for a decreased condition factor (k)
(BMDL05: 0.8 mg EQ/kg BW/day), in addition to its high biological relevance, the „severe
depletion of intracytoplasmic vacuoles”observed in the liver had the lowest BMDU/BMDL,
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and was thus the most reliable BMDL estimate. Hence, the BMDL10 of 3.2 mg EQ/kg BW/day
was considered the critical BMDL and is proposed as reference point for a safe upper exposure
level of EQ in Atlantic salmon.
Conclusion
The results from the present study indicated that subchronic dietary exposure to concentra-
tions above 119 mg EQ/kg feed perturb hepatic lipid and carbohydrate metabolism, leading to
a depletion of hepatic energy stores, which was associated with alterations in purine/pyrimi-
dine metabolism in Atlantic salmon. EQ-induced effects were associated with presence of oxi-
dative stress in the liver and activation of the NRF2-mediated oxidative stress response.
Although some changes in adaptive redox biomarkers were observed at lower doses, no
signs of adverse effects were observed in Atlantic salmon exposed to feed concentrations below
119 mg EQ/kg feed. A critical BMDL10 of 3.2 mg EQ/kg BW/day was established for the deple-
tion of intracytoplasmic vacuoles in the liver as the critical endpoint in this study. The
BMDL10 corresponds to a feed concentration of around 240 mg EQ/kg. However, maximum
surveyed EQ levels in fish feed show that this concentration is within the range of detected lev-
els, thus warranting the control of the level EQ supplementation.
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